
First Novel Biologic Approval for Sun Pharma: Indian Pharma making New Inroads

Perpetuating Big Pharma Race to Lead in Regenerative Therapies

Continuing Complexity in Diabetes Market– Drugs & Diagnostic Devices

M&A – Device Companies’ interest in software & portfolio driven deals in pharma

Round-Up of Scale-up Funding for March

FY 17-18 Deal Closures by Sathguru:
- Veterinary vaccine technology access for leading Indian animal health player
- Strategic Marketing Partnership for a differentiated cattle nutritional supplement developed by an Indian start-up with a leading Agri Inputs Company
- USD 2 Million Pre Series A fund raise from family offices of leading primary healthcare chain in NZ and Thailand based business group
- Structured partnership with Draeger for neonate cooler device developed by Pluss Advanced Technologies
- Divestment of stake by minority shareholders in SGD Pharma to Netherlands Glass Investment BV, an affiliate of Oaktree Capital
- Out-licensing of topical generic formulation for US market for a leading Israeli CDMO
- Transaction Advisory to RDP Workstations Pvt Ltd for investment from Bennett, Coleman and Company Ltd